Mitra is a Translational Biology Company committed to making accurate personalized cancer care more affordable through our proprietary technology CANScript™.
This technology enables physicians make an informed treatment decision for a cancer patient by determining the most optimal drug combination
It also enables rational drug development by identifying driver pathways/mutations